Sopharma AD-Sofia (WAR:SPH) Revenue : zł4,283 Mil (TTM As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Sopharma AD-Sofia Revenue?

Sopharma AD-Sofia's revenue for the three months ended in Jun. 2024 was zł1,071 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2024 was zł4,283 Mil. Sopharma AD-Sofia's Revenue per Share for the three months ended in Jun. 2024 was zł5.36. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was zł27.71.

Warning Sign:

Sopharma AD-Sofia revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Sopharma AD-Sofia was -9.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Sopharma AD-Sofia's highest 3-Year average Revenue per Share Growth Rate was 14.40% per year. The lowest was 4.30% per year. And the median was 9.80% per year.

Sopharma AD-Sofia Revenue Historical Data

The historical data trend for Sopharma AD-Sofia's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Revenue Chart

Sopharma AD-Sofia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Revenue

Get a 7-Day Free Trial

2,804.67

3,148.78

3,508.74

3,639.40

4,103.98

Sopharma AD-Sofia Quarterly Data
	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Revenue	Get a 7-Day Free Trial															984.11	1,002.50	1,094.92	1,114.96	1,070.97

Competitive Comparison of Sopharma AD-Sofia's Revenue

For the Medical Distribution subindustry, Sopharma AD-Sofia's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sopharma AD-Sofia's Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Revenue distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Revenue falls into.

Sopharma AD-Sofia Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł4,283 Mil.

Sopharma AD-Sofia (WAR:SPH) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Sopharma AD-Sofia Revenue Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (WAR:SPH) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

SFA:Bulgaria

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.